The appointments were announced along with the news that longtime Chief Communications Officer Michael Sneed will retire in 2022.

The target's lead product, Tissuepatch, bonds with tissue to help control internal bleeding or prevent leaks from surgical incisions.

The news came the same day drugmaker Pfizer announced that a third dose booster shot can “neutralize” the new variant, which was first detected in South Africa and has been spreading rapidly.

Hackensack Meridian Health announced it would expand Behavioral Health and Long Term Acute Care beds at the facility, which has served the community for more than 100 years.

Dr. Shefali Shah, board certified in otolaryngology and head and neck surgery will lead the practices.

Locations of the newly awarded permits are equally spread across North, Central and South Jersey.

Facilities were evaluated based on five factors: scheduled early deliveries; C-section rates in low-risk women; newborn complications; rate of exclusive breast milk feeding; and option for vaginal births after cesarean.

On Sunday, the state recorded 3,097 new positive cases and 1,113 people hospitalized with confirmed or suspected  infections across 68 of the its 71 hospitals.

The medical technology company is formally introducing "embecta," expected to close in the second quarter of 2022, a name with ties to its past, patients and the future.

It's the second recent deal for the company, coming on the heels of a similar five-year award with Florida State University.

The company is focused on developing drugs to treat debilitating and sometimes deadly diseases, including infectious diseases such as COVID-19; autoimmune diseases including rheumatoid arthritis; cachexia associated with AIDS and cancer; and retinal diseases.

Virtua Health announced the location will open next week in response to widening eligibility for boosters, but will serve anyone eligible, including those in need of a first shot.